PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 47 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 2.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $363,000 | -19.7% | 330,586 | 0.0% | 0.00% | – |
Q2 2020 | $452,000 | +20.2% | 330,586 | 0.0% | 0.00% | – |
Q1 2020 | $376,000 | -80.1% | 330,586 | -60.1% | 0.00% | – |
Q4 2019 | $1,890,000 | +444.7% | 829,438 | +101.6% | 0.00% | – |
Q3 2019 | $347,000 | -14.7% | 411,468 | -1.4% | 0.00% | – |
Q2 2019 | $407,000 | -29.9% | 417,176 | -9.6% | 0.00% | – |
Q1 2019 | $581,000 | -78.7% | 461,336 | -45.2% | 0.00% | – |
Q4 2018 | $2,728,000 | +340.0% | 842,070 | +226.9% | 0.00% | – |
Q3 2018 | $620,000 | -4.6% | 257,590 | +10.5% | 0.00% | – |
Q2 2018 | $650,000 | -18.5% | 233,193 | +38.7% | 0.00% | – |
Q1 2018 | $798,000 | +96.1% | 168,141 | +140.3% | 0.00% | – |
Q4 2017 | $407,000 | +154.4% | 69,976 | -8.3% | 0.00% | – |
Q3 2017 | $160,000 | -55.2% | 76,292 | 0.0% | 0.00% | – |
Q2 2017 | $357,000 | -50.3% | 76,292 | -17.0% | 0.00% | – |
Q1 2017 | $718,000 | -34.6% | 91,936 | +2.6% | 0.00% | -100.0% |
Q4 2016 | $1,098,000 | +37.2% | 89,565 | +74.4% | 0.00% | – |
Q3 2016 | $800,000 | +37.7% | 51,358 | +7.1% | 0.00% | – |
Q2 2016 | $581,000 | +41.0% | 47,955 | +12.1% | 0.00% | – |
Q1 2016 | $412,000 | – | 42,777 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 3,804,027 | $17,803,000 | 2.95% |
HARBOURVEST PARTNERS LLC | 440,627 | $2,062,000 | 0.89% |
NEA Management Company, LLC | 3,556,778 | $16,646,000 | 0.61% |
Rock Springs Capital Management LP | 450,000 | $2,106,000 | 0.11% |
Bain Capital Public Equity Management, LLC | 263,498 | $1,233,000 | 0.07% |
ELEMENT CAPITAL MANAGEMENT LLC | 65,973 | $309,000 | 0.06% |
Hillhouse Capital Management | 865,923 | $4,053,000 | 0.06% |
SABBY MANAGEMENT, LLC | 125,151 | $586,000 | 0.04% |
Marshall Wace North America L.P. | 684,124 | $3,421,000 | 0.02% |
FNY Partners Fund LP | 20,127 | $94,000 | 0.02% |